跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 273 条关于
“lecanumab-irmb”
全部
273
临床试验
81
药物
68
机构
1
资讯
123
去年
CT1812 Shows Promise in Alzheimer's Subgroup with Lower Tau Levels
去年
Eisai Seeks FDA Approval for Subcutaneous LEQEMBI® in Alzheimer's Maintenance Therapy
去年
Eisai Completes FDA Submission for Subcutaneous LEQEMBI® in Early Alzheimer's
去年
Eisai Completes FDA Submission for Subcutaneous Lecanemab in Early Alzheimer's
去年
Eisai Completes FDA Submission for Subcutaneous Lecanemab in Early Alzheimer's
去年
Eisai Completes FDA Submission for Subcutaneous Lecanemab in Alzheimer's Maintenance
2年前
Eisai Seeks FDA Approval for Subcutaneous Lecanemab in Alzheimer's Maintenance Therapy
3年前
FDA Accepts sBLA for Traditional Approval of LEQEMBI for Alzheimer's Disease Treatment
去年
Eisai Completes FDA Submission for Subcutaneous LEQEMBI Maintenance Dosing in Alzheimer's
去年
Alzheimer's Disease Pipeline Shows Promise with 120+ Therapies in Development
第 1 页,共 13 页
上一页
下一页